Green Star Products, Inc. has signed a Distribution Contract with Biotech Research, LLC, to market/sell their Broad-Spectrum Antiviral Product, called Viro Spectrum Shield (VSS), in several South American countries. VSS has been tested by a US Federally Accredited Laboratory and has been successfully proven to inhibit SARS-CoV-2 (Covid-19) virus in vitro. VSS was specifically tested and found to be effective against the Covid-19 virus as well as the A/H1N1, A/H2N3, B/H2N3 flu viruses in vitro, which demonstrates its Broad-Spectrum Antiviral Capability. VSS was also tested and found to be non-toxic in vitro. Additionally, over the past nine months numerous infected volunteers with serious flu-like symptoms, including those who have tested positive for Covid-19, have experienced Significantly Improved Health and Reduction of Symptoms (or Elimination) usually within 24 to 48 hours or less with no side effects. None of these people needed hospitalization.